+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-27Number of Pages: 189

Contraceptives Market (Product - Contraceptive Drugs (Oral Contraceptives (Combined Contraceptives and Mini-pills), Contraceptive Injectable, and Topical Contraceptive Patch) and Contraceptive Devices (Male Contraceptive Devices and Female Contraceptive Devices (Female Condoms, Contraceptive Diaphragms, Contraceptive Sponges, Contraceptive Vaginal Rings, Intrauterine Devices, Sub-dermal Contraceptive Implants, Non-surgical Permanent Contraception Devices)); Distribution Channel - Hospital Pharmacy (Public and Private), Independent Pharmacy, Online Platform, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Contraceptive Market 

4. Market Overview
      4.1. Introduction
      4.2. Overview
      4.3. Key Market Indicators
      4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
      4.5. Global Contraceptive Market  Analysis and Forecasts, 2015–2025
             4.5.1. Market Revenue Projections (US$ Mn)
      4.6. Contraceptive Market  - Global Supply Demand Scenario
      4.7. Porter’s Five Force Analysis
      4.8. Value Chain Analysis
      4.9. Market Outlook

5. Global Contraceptive Market  Analysis and Forecasts, By Product
      5.1. Introduction & Definition
      5.2. Key Findings / Developments
      5.3. Key Trends
      5.4. Market Value Forecast By Product , 2015–2025
             5.4.1. Contraceptive Drugs
                      5.4.1.1. Oral Contraceptives
                                 5.4.1.1.1. Combined Contraceptives
                                 5.4.1.1.2. Mini-pills
                      5.4.1.2. Contraceptive Injectable
                      5.4.1.3. Topical Contraceptive Patch
             5.4.2. Contraceptive Devices
                      5.4.2.1. Male Contraceptive Devices
                      5.4.2.2. Female Contraceptive Devices
                                 5.4.2.2.1. Female Condoms
                                 5.4.2.2.2. Contraceptive Diaphragms
                                 5.4.2.2.3. Contraceptive Sponges
                                 5.4.2.2.4. Contraceptive Vaginal Rings
                                 5.4.2.2.5. Intrauterine Devices
                                 5.4.2.2.6. Sub-dermal Contraceptives Implants
                                 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
      5.5. Market Attractiveness By Product

6. Global Contraceptive Market  Analysis and Forecasts, By Distribution Channel
      6.1. Introduction & Definition
      6.2. Key Findings / Developments
      6.3. Key Trends
      6.4. Market Value Forecast By Distribution Channel, 2015–2025
      6.4.1. Hospital Pharmacy
                      6.4.1.1. Public
                      6.4.1.2. Private
              6.4.2. Independent Pharmacy
              6.4.3. Online Platform
              6.4.4. Clinics
              6.4.5. Others
      6.5. Market Attractiveness By Distribution Channel

7. Global Contraceptive Market  Analysis and Forecasts, By Region
      7.1. Key Findings
      7.2. Policies and Regulations
      7.3. Market Value Forecast By Region
             7.3.1. North America 
             7.3.2. Europe 
             7.3.3. Asia Pacific 
             7.3.4. Latin America 
             7.3.5. Middle East and Africa 
      7.4. Market Attractiveness By Country/Region

8. North America Contraceptive Market  Analysis and Forecast
      8.1. Introduction
             8.1.1. Key Findings
             8.1.2. Policies and Regulations
             8.1.3. Key Trends
      8.2. Market Value Forecast By Product, 2015–2025
             8.2.1. Contraceptive Drugs
                      8.2.1.1. Oral Contraceptives
                                 8.2.1.1.1. Combined Contraceptives
                                 8.2.1.1.2. Mini-pills
                      8.2.1.2. Contraceptive Injectable
                      8.2.1.3. Topical Contraceptive Patch
             8.2.2. Contraceptive Devices
                      8.2.2.1. Male Contraceptive Devices
                      8.2.2.2. Female Contraceptive Devices
                                 8.2.2.2.1. Female Condoms
                                 8.2.2.2.2. Contraceptive Diaphragms
                                 8.2.2.2.3. Contraceptive Sponges
                                 8.2.2.2.4. Contraceptive Vaginal Rings
                                 8.2.2.2.5. Intrauterine Devices
                                 8.2.2.2.6. Sub-dermal Contraceptives Implants
                                 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
      8.3. Market Value Forecast By Distribution Channel, 2015–2025
             8.3.1. Hospital Pharmacy
                      8.3.1.1. Public
                      8.3.1.2. Private
             8.3.2. Independent Pharmacy
             8.3.3. Online Platform
             8.3.4. Clinics
             8.3.5.Others
      8.4. Market Value Forecast By Country, 2015–2025
             8.4.1. U.S.
             8.4.2. Canada
      8.5. Market Attractiveness Analysis 
             8.5.1. By Product
             8.5.2. By Distribution Channel
             8.5.3. By Country 

9. Europe Contraceptive Market  Analysis and Forecast
      9.1. Introduction
             9.1.1. Key Findings
             9.1.2. Policies and Regulations
             9.1.3. Key Trends
      9.2. Market Value Forecast By Product, 2015–2025
             9.2.1. Contraceptive Drugs
                      9.2.1.1. Oral Contraceptives
                                 9.2.1.1.1. Combined Contraceptives
                                 9.2.1.1.2. Mini-pills
                      9.2.1.2. Contraceptive Injectable
                      9.2.1.3. Topical Contraceptive Patch
             9.2.2. Contraceptive Devices
                      9.2.2.1. Male Contraceptive Devices
                      9.2.2.2. Female Contraceptive Devices
                                 9.2.2.2.1. Female Condoms
                                 9.2.2.2.2. Contraceptive Diaphragms
                                 9.2.2.2.3. Contraceptive Sponges
                                 9.2.2.2.4. Contraceptive Vaginal Rings
                                 9.2.2.2.5. Intrauterine Devices
                                 9.2.2.2.6. Sub-dermal Contraceptives Implants
                                 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
      9.3. Market Value Forecast By Distribution Channel, 2015–2025
             9.3.1. Hospital Pharmacy
                      9.3.1.1. Public
                      9.3.1.2. Private
             9.3.2. Independent Pharmacy
             9.3.3. Online Platform
             9.3.4. Clinics
             9.3.5. Others
      9.4. Market Value Forecast By Country, 2015–2025
             9.4.1. Germany
             9.4.2. France
             9.4.3. U.K.
             9.4.4. Spain
             9.4.5. Italy
             9.4.6. Russia
             9.4.7. Rest of Europe
      9.5. Market Attractiveness Analysis 
             9.5.1. By Product
             9.5.2. By Distribution Channel 
             9.5.4. By Country

10. Asia Pacific Contraceptive Market  Analysis and Forecast
      10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Key Trends
      10.2. Market Value Forecast By Product, 2015–2025
             10.2.1. Contraceptive Drugs
                      10.2.1.1. Oral Contraceptives
                                 10.2.1.1.1. Combined Contraceptives
                                 10.2.1.1.2. Mini-pills
                      10.2.1.2. Contraceptive Injectable
                      10.2.1.3. Topical Contraceptive Patch
             10.2.2. Contraceptive Devices
                      10.2.2.1. Male Contraceptive Devices
                      10.2.2.2. Female Contraceptive Devices
                                 10.2.2.2.1. Female Condoms
                                 10.2.2.2.2. Contraceptive Diaphragms
                                 10.2.2.2.3. Contraceptive Sponges
                                 10.2.2.2.4. Contraceptive Vaginal Rings
                                 10.2.2.2.5. Intrauterine Devices
                                 10.2.2.2.6. Sub-dermal Contraceptives Implants
                                 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
      10.3. Market Value Forecast By Distribution Channel, 2015–2025
             10.3.1. Hospital Pharmacy 
                      10.3.1.1 Public
                      10.3.1.2. Private
             10.3.2. Independent Pharmacy 
             10.3.3. Online Platforms 
             10.3.4. Clinics 
             10.3.5. Others
      10.4. Market Value Forecast By Country, 2015–2025
             10.4.1. China
             10.4.2. Japan
             10.4.3. India
             10.4.4. Australia & New Zealand
             10.4.5. Rest of Asia Pacific
      10.5. Market Attractiveness Analysis 
             10.5.1. By Product
             10.5.2. By Distribution Channel
             10.5.3. By Country

11. Latin America Contraceptive Market  Analysis and Forecast
      11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3. Key Trends
      11.2. Market Value Forecast By Product , 2015–2025
             11.2.1. Contraceptive Drugs
                      11.2.1.1. Oral Contraceptives
                                 11.2.1.1.1. Combined Contraceptives
                                 11.2.1.1.2. Mini-pills
                      11.2.1.2. Contraceptive Injectable
                      11.2.1.3. Topical Contraceptive Patch
             11.2.2. Contraceptive Devices
                      11.2.2.1. Male Contraceptive Devices
                      11.2.2.2. Female Contraceptive Devices
                                 11.2.2.2.1. Female Condoms
                                 11.2.2.2.2. Contraceptive Diaphragms
                                 11.2.2.2.3. Contraceptive Sponges
                                 11.2.2.2.4. Contraceptive Vaginal Rings
                                 11.2.2.2.5. Intrauterine Devices
                                 11.2.2.2.6. Sub-dermal Contraceptives Implants
                                 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
      11.3. Market Value Forecast By Distribution Channel, 2015–2025
             11.3.1. Hospital Pharmacy 
                      11.3.1.1. Public
                      11.3.1.2. Private
             11.3.2. Independent Pharmacy 
             11.3.3. Online Platforms 
             11.3.4. Clinics 
             11.3.5. Others
      11.4. Market Value Forecast By Country, 2015–2025
             11.4.1. Brazil
             11.4.2. Mexico
             11.4.3. Rest of Latin America
      11.5. Market Attractiveness Analysis 
             11.5.1. By Product
             11.5.2. By Distribution Channel
             11.5.4. By Country

12. Middle East and Africa Contraceptive Market  Analysis and Forecast
      12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Policies and Regulations
             12.1.3. Key Trends
      12.2. Market Value Forecast By Product, 2015–2025
             12.2.1. Contraceptive Drugs
                      12.2.1.1. Oral Contraceptives
                                 12.2.1.1.1. Combined Contraceptives
                                 12.2.1.1.2. Mini-pills
                      12.2.1.2. Contraceptive Injectable
                      12.2.1.3. Topical Contraceptive Patch
             12.2.2. Contraceptive Devices
                      12.2.2.1. Male Contraceptive Devices
                      12.2.2.2. Female Contraceptive Devices
                                 12.2.2.2.1. Female Condoms
                                 12.2.2.2.2. Contraceptive Diaphragms
                                 12.2.2.2.3. Contraceptive Sponges
                                 12.2.2.2.4. Contraceptive Vaginal Rings
                                 12.2.2.2.5. Intrauterine Devices
                                 12.2.2.2.6. Sub-dermal Contraceptives Implants
                                 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
      12.3. Market Value Forecast By End User , 2015–2025
             12.3.1. Hospital Pharmacy 
                      12.3.1.1. Public
                      12.3.1.2. Private
             12.3.2. Independent Pharmacy
             12.3.3. Online Platform
             12.3.4. Clinics
             12.3.5. Others
      12.4. Market Value Forecast By Country , 2015–2025
             12.4.1. GCC Countries
             12.4.2. South Africa
             12.4.3. Rest of Middle East and Africa
      12.5. Market Attractiveness Analysis 
             12.5.1. By Product
             12.5.2. By Distribution Channel 
             12.5.3. By Country

13. Competition Landscape
      13.1. Market Player – Competition Matrix (By Tier and Size of companies)
      13.2. Market Share Analysis By Company (2016)
      13.3. Company Profiles 
             13.3.1. Merck & Co., Inc.
                      13.4.1.1. Overview
                      13.4.1.2. Financials
                      13.4.1.3. Recent Developments
                      13.4.1.4. Strategy
             13.3.2. Cipla Inc.
                      13.4.2.1. Overview
                      13.4.2.2. Financials
                      13.4.2.3. Recent Developments
                      13.4.2.4. Strategy
             13.3.3. Allergan plc
                      13.4.3.1. Overview
                      13.4.3.2. Financials
                      13.4.3.3. Recent Developments
                      13.4.3.4. Strategy
             13.3.4. Bayer AG
                      13.4.4.1. Overview
                      13.4.4.2. Financials
                      13.4.4.3. Recent Developments
                      13.4.4.4. Strategy
             13.3.5. HLL Lifecare Limited
                      13.4.5.1. Overview
                      13.4.5.2. Financials
                      13.4.5.3. Recent Developments
                      13.4.5.4. Strategy
             13.3.6. Mankind Pharma
                      13.4.6.1. Overview
                      13.4.6.2. Financials
                      13.4.6.3. Recent Developments
                      13.4.6.4. Strategy
             13.3.7. Pfizer, Inc.
                      13.4.7.1. Overview
                      13.4.7.2. Financials
                      13.4.7.3. Recent Developments
                      13.4.7.4. Strategy
             13.3.8. Teva Pharmaceutical Industries Ltd
                      13.4.8.1. Overview
                      13.4.8.2. Financials
                      13.4.8.3. Recent Developments
                      13.4.8.4. Strategy
             13.3.9. Mithra Pharmaceuticals
                      13.4.9.1. Overview
                      13.4.9.2. Financials
                      13.4.9.3. Recent Developments
                      13.4.9.4. Strategy
             13.3.10. Janssen Pharmaceutical Company
                      13.4.10.1. Overview
                      13.4.10.2. Financials
                      13.4.10.3. Recent Developments
                      13.4.10.4. Strategy
             13.3.11. Reckitt Benckiser Group plc
                      13.4.11.1. Overview
                      13.4.11.2. Financials
                      13.4.11.3. Recent Developments
                      13.4.11.4. Strategy

List of Figures

Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global Contraceptives Market Value Share, by Product (2016)
Figure 03: Global Contraceptives Market Value Share, by Distribution Channel (2016)
Figure 04: Global Contraceptives Market Value Share, by Region (2016)
Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 06: Global Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2025
Figure 08: Global Contraceptives Market Attractiveness, by Contraceptive Drugs, 2017–2025
Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2025
Figure 10: Global Contraceptives Market Attractiveness, by Oral Contraceptives, 2017–2025
Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2025
Figure 12: Global Contraceptives Market Attractiveness, by Contraceptive Devices, 2017–2025
Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2025
Figure 14: Global Contraceptives Market Attractiveness, by Female Contraceptive Devices, 2017–2025
Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive  Drugs, 2015–2025
Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2015–2025
Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 18: Global Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2015–2025
Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2015–2025
Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2015–2025
Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2015–2025
Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2025 
Figure 25: Global Contraceptives Market Attractiveness, by Region, 2017–2025
Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 27: North America Contraceptives Market Attractiveness, by Country 2017–2025
Figure 28: North America Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 30: North America Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 32: North America Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 34: Europe Contraceptives Market Attractiveness, by Country, 2017–2025
Figure 35: Europe Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2025
Figure 37: Europe Contraceptives Market Attractiveness, by Product, 2017–2025
Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 39: Europe Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 41: Asia Pacific Contraceptives Market Attractiveness, by Country 2017–2025
Figure 42: Asia Pacific Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 44: Asia Pacific Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 46: Asia Pacific Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 48: Latin America Contraceptives Market Attractiveness, by Country 2017–2025
Figure 49: Latin America Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 51: Latin America Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 53: Latin America Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 55: Middle East & Africa Contraceptives Market Attractiveness, by Country 2017–2025
Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 58: Middle East & Africa Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 60: Middle East & Africa Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 61: Global Contraceptives Drugs Market Share, by Company, 2016 
Figure 62: Global Contraceptives Devices Market Share, by Company, 2016

List of Tables

Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025


 
 
Back To Top